Cargando…
Epileptic seizure after treatment with thiocolchicoside
BACKGROUND: Adverse drug reactions are important determinants of inpatient and outpatient morbidity. Thiocolchicoside is a semisynthetic derivate of naturally occurring colchicoside, which is largely used in humans as a centrally acting muscle relaxant. Epileptic seizures after thiocolchicoside inta...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731019/ https://www.ncbi.nlm.nih.gov/pubmed/19707540 |
_version_ | 1782170920687763456 |
---|---|
author | Giavina-Bianchi, Pedro Giavina-Bianchi, Mara Tanno, Luciana Kase Ensina, Luis Felipe Chiaverini Motta, Antôno Abílio Kalil, Jorge |
author_facet | Giavina-Bianchi, Pedro Giavina-Bianchi, Mara Tanno, Luciana Kase Ensina, Luis Felipe Chiaverini Motta, Antôno Abílio Kalil, Jorge |
author_sort | Giavina-Bianchi, Pedro |
collection | PubMed |
description | BACKGROUND: Adverse drug reactions are important determinants of inpatient and outpatient morbidity. Thiocolchicoside is a semisynthetic derivate of naturally occurring colchicoside, which is largely used in humans as a centrally acting muscle relaxant. Epileptic seizures after thiocolchicoside intake have been reported in individuals with a history of epilepsy, acute brain injury or possible blood–brain barrier disruption. CASE REPORT: We report the case of a 66-year-old male patient presenting a sudden epileptic seizure temporally related to the intake of thiocolchicoside for muscle contracture and pain. The probably causes of the seizures were thiocolchicoside intake and cerebral microhemorrhages attributed to cerebral amyloid angiopathy. DISCUSSION: Drugs only rarely cause focal seizures. Our case indicates that thiocolchicoside can precipitate seizures in predisposed patients, and that its use should be avoided in patients with brain diseases (and therefore lower seizure thresholds) or blood–brain barrier disruption. This information should be provided in the drug package insert. |
format | Text |
id | pubmed-2731019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27310192009-08-25 Epileptic seizure after treatment with thiocolchicoside Giavina-Bianchi, Pedro Giavina-Bianchi, Mara Tanno, Luciana Kase Ensina, Luis Felipe Chiaverini Motta, Antôno Abílio Kalil, Jorge Ther Clin Risk Manag Case Report BACKGROUND: Adverse drug reactions are important determinants of inpatient and outpatient morbidity. Thiocolchicoside is a semisynthetic derivate of naturally occurring colchicoside, which is largely used in humans as a centrally acting muscle relaxant. Epileptic seizures after thiocolchicoside intake have been reported in individuals with a history of epilepsy, acute brain injury or possible blood–brain barrier disruption. CASE REPORT: We report the case of a 66-year-old male patient presenting a sudden epileptic seizure temporally related to the intake of thiocolchicoside for muscle contracture and pain. The probably causes of the seizures were thiocolchicoside intake and cerebral microhemorrhages attributed to cerebral amyloid angiopathy. DISCUSSION: Drugs only rarely cause focal seizures. Our case indicates that thiocolchicoside can precipitate seizures in predisposed patients, and that its use should be avoided in patients with brain diseases (and therefore lower seizure thresholds) or blood–brain barrier disruption. This information should be provided in the drug package insert. Dove Medical Press 2009 2009-08-20 /pmc/articles/PMC2731019/ /pubmed/19707540 Text en © 2009 Giavina-Bianchi et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Case Report Giavina-Bianchi, Pedro Giavina-Bianchi, Mara Tanno, Luciana Kase Ensina, Luis Felipe Chiaverini Motta, Antôno Abílio Kalil, Jorge Epileptic seizure after treatment with thiocolchicoside |
title | Epileptic seizure after treatment with thiocolchicoside |
title_full | Epileptic seizure after treatment with thiocolchicoside |
title_fullStr | Epileptic seizure after treatment with thiocolchicoside |
title_full_unstemmed | Epileptic seizure after treatment with thiocolchicoside |
title_short | Epileptic seizure after treatment with thiocolchicoside |
title_sort | epileptic seizure after treatment with thiocolchicoside |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731019/ https://www.ncbi.nlm.nih.gov/pubmed/19707540 |
work_keys_str_mv | AT giavinabianchipedro epilepticseizureaftertreatmentwiththiocolchicoside AT giavinabianchimara epilepticseizureaftertreatmentwiththiocolchicoside AT tannolucianakase epilepticseizureaftertreatmentwiththiocolchicoside AT ensinaluisfelipechiaverini epilepticseizureaftertreatmentwiththiocolchicoside AT mottaantonoabilio epilepticseizureaftertreatmentwiththiocolchicoside AT kaliljorge epilepticseizureaftertreatmentwiththiocolchicoside |